To learn about other mild side effects, talk with your doctor or pharmacist, or read Keytruda’s prescribing information. Mild side effects of Keytruda that have been reported include ...

Magazine illustrations, advertisements and government information posters, published during World War Two, offer a fascinating insight into social attitudes of the time - as well as the impact of ...

Merck & Co's FDA approval for Keytruda in advanced liver cancer looks secure, after an Asian clinical trial found that the cancer immunotherapy improved survival in these patients. Keytruda ...

Keytruda in early-stage triple-negative breast cancer led to immune-related adverse effects, including severe GI issues and ...

Moderna and MSD have initiated a Phase III clinical study to evaluate mRNA-4157 (V940), an investigational individualised ...

When your ideas need to have impact, think poster. And to be presentation ready, University Print is your resource for printing high-quality, large format posters and other materials for your class ...

In MSI-H or dMMR endometrial cancer, Keytruda achieved an objective response rate (ORR) of 46%, including 12% complete responses and 33% partial responses, after a median of 16 months' follow-up.

The company saw strong sales from its top-selling cancer drug Keytruda, recently launched treatments and its animal health ...

To submit a poster through SciServiceRequests: Gather the following information: Poster title Poster file in PDF format If you are at Brandeis, you may have the option to pay with a chargeline. You ...

Merck (NYSE:MRK) announced Tuesday that its Phase 3 KEYNOTE-689, designed to evaluate its anti-PD-1 therapy Keytruda as a ...

Investors in Merck don't seem pleased with a competitor cancer-treatment candidate outperforming Keytruda. Summit Therapeutics says its monotherapy ivonescimab outperformed pembrolizumab ...